Equities Research Analysts’ new coverage for Tuesday, March 5th:
William Blair initiated coverage on shares of Bristol Myers Squibb (NYSE: BMY). They issued an outperform rating on the stock.
Piper Jaffray started coverage on shares of Clovis Oncology (NASDAQ: CLVS). Piper Jaffray issued a neutral rating and a $20.00 target price on the stock.
Northland Securities started coverage on shares of Edap – Tms SA (NASDAQ: EDAP). They issued an outperform rating and a $6.00 price target on the stock.
Oppenheimer started coverage on shares of FedEx (NYSE: FDX). Oppenheimer issued an outperform rating and a $124.00 price target on the stock.
Raymond James initiated coverage on shares of Health Insurance Innovations (NASDAQ: HIIQ). Raymond James issued a strong-buy rating and a $19.00 price target on the stock.
Sidoti assumed coverage on shares of Krispy Kreme Doughnuts (NYSE: KKD). Sidoti issued a buy rating and a $18.00 price target on the stock.
Piper Jaffray began coverage on shares of Navidea Biopharmaceuticals (NASDAQ: NAVB). The firm issued an underweight rating and a $1.50 target price on the stock.
Stifel Nicolaus started coverage on shares of New Source Energy Partners LP (NASDAQ: NSLP). Stifel Nicolaus issued a buy rating on the stock.
Piper Jaffray initiated coverage on shares of Peregrine Pharmaceuticals (NASDAQ: PPHM). Piper Jaffray issued an overweight rating and a $2.50 price target on the stock.
Craig Hallum initiated coverage on shares of Trinity Biotech plc (NASDAQ: TRIB). Craig Hallum issued a buy rating on the stock.
Oppenheimer began coverage on shares of United Parcel Service (NYSE: UPS). They issued an outperform rating and a $95.00 target price on the stock.
Piper Jaffray assumed coverage on shares of Vanda Pharmaceuticals (NASDAQ: VNDA). They issued an overweight rating and a $8.00 price target on the stock.
Piper Jaffray initiated coverage on shares of VIVUS (NASDAQ: VVUS). The firm issued an overweight rating and a $17.00 price target on the stock.
Scotiabank started coverage on shares of Westshore Terminals Income Fund (TSE: WTE). They issued a sector perform rating and a $30.00 price target on the stock.
Scotiabank initiated coverage on shares of Westshore Terminals Investment (TSE: WTE.UN). They issued a sector perform rating and a $30.00 target price on the stock.
Scotiabank initiated coverage on shares of Westshore Terminals Investment (TSE: WTE.UN). The firm issued a sector perform rating and a $30.00 target price on the stock.
Barclays Capital assumed coverage on shares of ZAIS Financial Corp (NYSE: ZFC). The firm issued an overweight rating and a $23.00 target price on the stock.
Citigroup started coverage on shares of ZAIS Financial Corp (NYSE: ZFC). The firm issued a buy rating and a $22.00 price target on the stock.
Brinson Patrick started coverage on shares of Zogenix (NASDAQ: ZGNX). Brinson Patrick issued an outperform rating and a $5.00 target price on the stock. The analysts wrote, “Given the number of issues surrounding the FDA’s decision on Zohydro ER’s approval, we had suspected the FDA would take actions that would put Zohydro ER at a marketing disadvantage to the other extended release opioids. But as a result of Zogenix’s informal communications with the agency last week, we believe Zohydro ER will be approved in the next few weeks with prescribing and distribution restrictions that are similar to other extended release opioids. Not only did the FDA not ask for additional data or issue a three month extension, but in Zogenix’s press release the company described Zohydro ER’s REMS as “consistent with…” similar drugs.”
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
